Kathleen Cox, director of exploratory drug metabolism of the Schering-Plough Research Institute, will discuss the drug discovery process during the 20th annual Leonard A. Ford Lectureship Monday, Sept. 14, at Minnesota State Mankato.
Cox’s lecture, hosted by the Department of Chemistry & Geology, is titled “The Small-Molecule Drug Discovery Process: From Molecules to Medicine.” It will be at 7:30 p.m. in Room C121 of Trafton Science Center, followed by a reception.
Cox also will give a technical talk, “Use of LC-MS/MS for Metabolite Characterization in Drug Discovery,” at noon Sept. 14 in Ford Hall 216. Her lecture will discuss the discovery process for obesity/metabolic syndrome therapy, with the indication of type 2 diabetes.
Students, faculty, staff and the public are welcome to attend both free events.
Cox points out that the drug discovery process depends on a unique series of successful collaborations among different disciplines. The integrated efforts of biologists, chemists, clinicians, market experts and regulatory experts identify emerging fields and molecular targets for drug discovery, assess unmet medical needs and feasibility of success, and analyze the regulatory climate.
Those with a disability who need a reasonable accommodation to attend the lecture may call (507) 389-1963 or 711 (MRS/TTY).
Email this article | Permanent link | Topstories news | Topstories news archives
Minnesota State
University, Mankato
Mankato, MN 56001
1-800-722-0544
© 2005-2013 Minnesota State University, Mankato. Minnesota State University, Mankato is a member of
Minnesota State Colleges & Universities system and an affirmative action/equal opportunity university.
